Compare RLX Technology Inc (RLX) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
RLX Technology Inc vs Viatris Inc — how do they compare? RLX Technology Inc trades at $2.03 (market cap $2.52B), while Viatris Inc trades at $17.58 (market cap $19.79B). The key difference: Viatris Inc is far larger — about 7.9× RLX Technology Inc's market cap, and RLX Technology Inc pays the higher dividend (4.85%). Which is the better fit depends on your goals.
| RLX | VTRS | |
|---|---|---|
Market Cap | $2.52B | $19.79B |
Sector | Technology | Health |
52-Week High | $2.73 | $17.39 |
52-Week Low | $1.79 | $8.74 |
Enterprise Value | $1.15B | $32.00B |
Dividend Yield | 4.85% | 2.83% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About RLX Technology Inc
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
